Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2016 (2016), Article ID 3152495, 5 pages
http://dx.doi.org/10.1155/2016/3152495
Case Report

Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant Recipient

1Departments of Nephrology and Transplantation, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
2Department of Virology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
3Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
4Department of Histopathology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

Received 5 June 2016; Accepted 8 September 2016

Academic Editor: David Conti

Copyright © 2016 Tracey Salter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. CDC, “Recommendations for preventing transmission of infections among chronic hemodialysis patients,” Morbidity and Mortality Weekly Report: Recommendations and Reports, vol. 50, pp. 1–43, 2001. View at Google Scholar
  2. Renal Association Guidelines, http://www.renal.org/guidelines/modules/blood-borne-virus-infection#S5.
  3. http://kdigo.org/clinical_practice_guidelines/pdf/TxpGL_publVersion.pdf.
  4. Clinical Practice Guidelines, Post-Operative Care of the Kidney Transplant Recipient, Guideline 8.1.2, UK Renal Association, 5th edition, 2011.
  5. R. L. Da Silva, “Viral-associated thrombotic microangiopathies,” Hematology/Oncology and Stem Cell Therapy, vol. 4, no. 2, pp. 51–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. F. Charest, A. Grand'Maison, J. McDougall, and M. B. Goldstein, “Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population,” American Journal of Kidney Diseases, vol. 42, no. 6, pp. 1193–1199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Tsouchnikas, E. Dounousi, K. Xanthopoulou, S. Papakonstantinou, V. Thomoglou, and D. Tsakiris, “Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination,” Clinical Nephrology, vol. 68, no. 4, pp. 228–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. T. Chung, S. Feng, and F. L. Delmonico, “Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor,” American Journal of Transplantation, vol. 1, no. 2, pp. 185–191, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. L. G. Rubin, M. J. Levin, P. Ljungman et al., “2013 IDSA clinical practice guideline for vaccination of the immunocompromised host,” Clinical Infectious Diseases, vol. 58, no. 3, pp. e44–e100, 2014. View at Publisher · View at Google Scholar
  10. C. Loinaz, J. R. de Juanes, E. Moreno Gonzalez et al., “Hepatitis B vaccination results in 140 liver transplant recipients,” Hepatogastroenterology, vol. 44, no. 13, pp. 235–238, 1997. View at Google Scholar · View at Scopus
  11. S.-H. Chang, K.-S. Suh, N.-J. Yi et al., “Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation,” Hepatology, vol. 37, no. 6, pp. 1329–1334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Serrano, J.-M. Bayas, L. Bruni, and C. Díez, “Solid organ transplantation and response to vaccination,” Vaccine, vol. 25, no. 42, pp. 7331–7338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. J. Grob, U. Binswanger, K. Zaruba et al., “Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients,” Antiviral Research, vol. 3, no. 1, pp. 43–52, 1983. View at Publisher · View at Google Scholar · View at Scopus
  14. European Consensus Group on Hepatitis B Immunity, “Are booster immunisations needed for lifelong hepatitis B immunity?” The Lancet, vol. 355, pp. 561–565, 2000. View at Google Scholar